Bank­rupt and weary, di­et pill mak­er Orex­i­gen to sell for $75M to Nal­pro­pi­on

Di­et pill mak­er Orex­i­gen Ther­a­peu­tics can fi­nal­ly turn out the lights. Af­ter a years-long bat­tle to bring its fi­nances in­to the black, the com­pa­ny put …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA